The COVID-19 pandemic has occupied the world agenda since December 2019. With no
effective treatment yet, vaccination seems to be the most effective method of prevention …

In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on
vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This …

Aim People with rheumatic diseases (PRD) remain vulnerable in the era of the COVID‐19
pandemic. We formulated recommendations to meet the urgent need for a consensus for …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has caused more than 100
million infections and 2 million deaths worldwide. In up to 20% of cases, COVID-19 infection …

Objectives Successful vaccination is key to overcoming the COVID-19 pandemic.
Immunosuppressive medication is known to potentially compromise vaccination responses …

Objective: To provide guidelines on the coronavirus disease 2019 (COVID-19) vaccination
in patients with immune-mediated rheumatic diseases (IMRD) to rheumatologists …

Abstract Purpose of Review Three COVID-19 vaccines obtained emergency authorization
from the Food and Drug Administration (FDA) and are widely used in the USA …

Patients with a systemic autoimmune rheumatic disease (AIRD) are vulnerable to SARS Cov-
2 infection. Vaccination against this infection can prevent the patients from developing …

Objective To provide guidance to rheumatology providers on the use of coronavirus disease
2019 (COVID‐19) vaccines for patients with rheumatic and musculoskeletal diseases …

Vaccination against SARS-CoV-2 has become available and will hopefully end the current
pandemic. Understandably, patients with inflammatory rheumatic diseases (iRMDs) and …